HedgeChatter

  • Home /
  • Tag Archives

LLY

Eli Lilly to buy Novartis’ animal health business for $5.4 bln

[Reuters] – Eli Lilly and Co said on Tuesday it will buy Novartis AG’s animal health business for $5.4 billion in cash to strengthen and diversify its Elanco unit. Lilly said it plans to fund the deal with about $3.4 billion of cash on hand and borrow $2 moreView todays social media effects on LLYView the latest stocks trending across […]

April 22, 2014 Bystocknews , Comments Off on Eli Lilly to buy Novartis’ animal health business for $5.4 bln read more

Novartis exhanges assets with Glaxosmithkline

moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, click here to view […]

April 22, 2014 Bystocknews , Comments Off on Novartis exhanges assets with Glaxosmithkline read more

Lilly Announces Agreement to Acquire Novartis Animal Health

[PR Newswire] – INDIANAPOLIS, April 22, 2014 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced an agreement to acquire Novartis Animal Health for approximately $5.4 billion in an all-cash transaction that … moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, click here to view […]

April 22, 2014 Bystocknews , Comments Off on Lilly Announces Agreement to Acquire Novartis Animal Health read more

Lilly’s CYRAMZAâ„¢ (ramucirumab) Becomes First FDA-Approved Treatment for Advanced Gastric Cancer After Prior Chemotherapy

[PR Newswire] – INDIANAPOLIS, April 21, 2014 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZAâ„¢ (ramucirumab) as a single-agent treatment … moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, click here to view […]

April 22, 2014 Bystocknews , Comments Off on Lilly’s CYRAMZAâ„¢ (ramucirumab) Becomes First FDA-Approved Treatment for Advanced Gastric Cancer After Prior Chemotherapy read more

Eli Lilly’s $3 Billion Mistake

moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, click here to view […]

April 14, 2014 Bystocknews , Comments Off on Eli Lilly’s $3 Billion Mistake read more

9:18 am Eli Lilly responds to verdict in case of Terrence Allen v. Takeda (TKPYY); says ‘believes the evidence did not support his claims’

moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, click here to view […]

April 9, 2014 Bystocknews , Comments Off on 9:18 am Eli Lilly responds to verdict in case of Terrence Allen v. Takeda (TKPYY); says ‘believes the evidence did not support his claims’ read more

[$$] Takeda, Lilly Ordered to Pay $9 Billion in Diabetes-Drug Case

[at The Wall Street Journal] – Takeda Pharmaceutical and Eli Lilly face a total of $9 billion in punitive damages after a U.S. jury decided that they hid the cancer risks of their Actos diabetes drug. moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, click here […]

April 9, 2014 Bystocknews , Comments Off on [$$] Takeda, Lilly Ordered to Pay $9 Billion in Diabetes-Drug Case read more

Ethical Drug Stocks Are Struggling

moreView todays social media effects on LLYView the latest stocks trending across Twitter. Click to view dashboardSee who Eli is hiring next, click here to view […]

April 8, 2014 Bystocknews , Comments Off on Ethical Drug Stocks Are Struggling read more